Navigation Links
Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
Date:2/7/2013

5 million people globally suffer from Parkinson's disease, a neurodegenerative disorder caused by the diminished production of dopamine, a key neurotransmitter, resulting in progressive impairment of motor function including tremors, rigidity and difficulty in moving. Long-term treatment of Parkinson's disease (PD) patients with levodopa, also called L-dopa, typically leads to unwanted side effects including L-dopa induced dyskinesia (LID), which prevents optimal treatment of the disease.

L-dopa Induced Dyskinesia
Levodopa, also called L-dopa, is the most commonly administered drug to treat Parkinson's symptoms. L-dopa helps restore levels of dopamine, a chemical messenger in the brain responsible for smooth, coordinated movement and other motor and cognitive functions. Dyskinesia is a common side effect of L-dopa treatment. These involuntary, uncontrollable, and often excessive movements are distinct from the rhythmic tremor commonly associated with Parkinson's disease.

About Metabolic Solutions Development Company
Metabolic Solutions Development Company (www.msdrx.com) is a drug discovery and development company investigating novel molecular targets and developing new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially type 2 diabetes.

About The Michael J. Fox Foundation for Parkinson's Research
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers. In addition to funding more than $313 million in research to date, the Foundation has fundamenta
'/>"/>

SOURCE Metabolic Solutions Development Company, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics
2. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
3. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
4. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
5. New Wellness Products with Results that Identify Healthiness, Deficiencies and Solutions
6. H. D. Smith Specialty Solutions Appoints 20-year Industry Veteran Tim Booth To Executive Vice President, Smith Medical Partners
7. BioLife Solutions Appoints Rick Stewart To Board of Directors
8. New Findings Offer Systemic Solutions to Address Non-communicable Diseases (NCDs) in Low- and Middle-income Countries
9. Omnicell to Showcase Automation Solutions at Arab Health 2013
10. Elekta to Showcase Broad Portfolio of Cancer Management Solutions at 2013 Arab Health Congress and Exhibition
11. H. D. Smith Establishes Specialty Solutions Organization And Realigns Senior Leadership To Support Growing Geographic Reach, Diversified Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... - The issue: In consultation ... lot (lot 710535) of Clavulin-400 (70mL) after receiving a complaint ... in one bottle of the  product. No other lots of ... Clavulin-400 is an oral antibiotic used in adults and children ... Clavulin-400 comes as a powder in bottles and is mixed ...
(Date:4/17/2015)... , April 17, 2015 Contego ... Integrated Embolic Protection™ filter platform for angioplasty balloon ... a $5.6 million Series B financing round led ... firm with a focus on medical devices, biopharmaceuticals, ... round also included Mountain Group Partners, Lookout Capital ...
(Date:4/17/2015)... April 17, 2015  Regulatory leaders in the pharmaceutical ... discussion draft called "21 st Century Cures." ... be taken up by Congress soon and if enacted ... device products are developed and marketed in ... companies have begun to consider how the proposed changes ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... 17, 2011 Xanodyne Pharmaceuticals, Inc., is pleased to ... position of Chief Operating Officer reporting to Natasha Giordano, ... has more than 20 years of experience in the ... senior positions in UCB Pharmaceuticals (Belgium, US and Japan). ...
... Cynosure, Inc. (Nasdaq: CYNO ), a ... invasive and non-invasive aesthetic applications, today announced the ... Company,s new flagship workstations for cellulite reduction. ... Australia,s Therapeutic Goods Administration (TGA) for its Cellulaze™ ...
Cached Medicine Technology:Xanodyne Pharmaceuticals Appoints New Chief Operating Officer 2Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations 2Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations 3
(Date:4/19/2015)... 2015 Carinsurancehints.com has released a new blog ... claim auto insurance benefits . , Drivers who ... all the necessary information for claiming auto insurance benefits. Exchanging ... plan to cover most of the damages. The newly released ... an accident. , Drivers can compare online rates and ...
(Date:4/19/2015)... April 19, 2015 The American Institute ... with PROSHRED Security (“PROSHRED”) to host its second annual, ... shred their personal documents in order to raise funds ... , The June 6th event is being held at ... 2pm local time. The time will vary at select ...
(Date:4/19/2015)... HealthPostures, LLC , a leading ... exhibit it’s pioneering ergonomics products at the Wisconsin Safety ... Council Professional Development Conference and Expo . The products, ... used in volume by call centers, educational organizations, retailers, ... clamp to a desk, the TaskMate Go 6350 and ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post explaining ... Spring. , Spring can be a great season ... sure they compare the newest policies before deciding on ... about Spring car insurance offers by reading the newly ... becoming more and more popular. Many insurance brokerage websites ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post ... . , Clients can review important auto insurance ... environment provides important advantages for clients who need affordable ... do not have coverage for their vehicles can purchase ... or hour. Many agencies offer important discounts and drivers ...
Breaking Medicine News(10 mins):Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2Health News:2015 Annual Nationwide "Shred Cancer" Shredding Event 2Health News:HealthPostures' TaskMate Products to be Exhibited at the Wisconsin and Iowa-Illinois Safety Conferences 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2
... at Washington University School of Medicine in St. Louis ... a common irregular heartbeat. Available at only a ... minimally invasive surgical techniques with the latest advances in ... heart,s inner surface to block signals causing the heart ...
... with Asperger syndrome have problems with social interaction and ... Several of these characteristics were evident to parents during ... in psychology at the University of Gothenburg. ... syndrome aged 14-24 perceive themselves relative to their diagnosis. ...
... The process of cell division is tightly regulated, as mistakes ... fingered as causing tumors in both skin and liver. ... Medicine, Vienna, has now uncovered a surprising detail with the ... an important anti-tumor factor. The results have recently been ...
... 28, 2011 Nurses, occupational and physical therapists, ... at a 300-bed Nebraska rehabilitation hospital, have successfully ... from urinary catheters, the most prevalent type of ... team at Madonna Rehabilitation Hospital in Lincoln, one ...
... show that screening with mammography reduces the number of deaths ... Mary, University of London, shows that the number of deaths ... results are new evidence of the long-term benefits of regular ... cancer can take many years to develop so to tell ...
... , MONDAY, June 27 (HealthDay News) -- Blood pressure ... home monitoring device appear more effective than blood pressure ... patients with chronic kidney disease will experience kidney failure ... study that included 436 chronic kidney disease patients who ...
Cached Medicine News:Health News:New procedure treats atrial fibrillation 2Health News:New procedure treats atrial fibrillation 3Health News:New procedure treats atrial fibrillation 4Health News:The good, the bad and the ugly: The many roles of c-JUN in cancer 2Health News:Team approach reduces urinary tract infections in rehab patients 2Health News:At-Home Blood Pressure Monitoring More Telling Than Doctor's Office Readings 2
...
... Embolic Protection Device features the ability to ... the lesion and a pre-loaded nitinol filter ... recovery. Offering a fully rapid exchange system, ... in the indicated applications:, Carotid Indication - ...
Clot-based Assay for Anti-FXa and/or Anti-Iia Therapies...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Medicine Products: